Ph.D., Professor of Health Economics and Founding Director, UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), Department of Clinical Pharmacy, UCSF
Kathryn Phillips examines how new technologies can be effectively and efficiently translated into clinical care and health policy. A particular focus is reimbursement policies and economic analyses of precision medicine. Current project include an R01 on benefit/risk tradeoffs for multigene tests; the value of precision medicine and digital medicine in a global context (supported by the Rockefeller Foundation); and a review of comparative effectiveness research on precision medicine (with PCORI). Her work spans multiple disciplines, including basic, clinical and social sciences, and brings together leading experts from academia, industry, insurers, and government. Kathryn has published >130 articles in major journals (e.g., JAMA, New England Journal of Medicine, Health Affairs) and has had continuous funding as an NIH Principal Investigator for >25 years. She serves on the editorial boards for Health Affairs and leading journals on precision medicine, and has served as an advisor to >35 biotechnology and venture capital firms.
Reimbursement for Multigene Tests: The Good, The Bad, and The Ugly
Reimbursement is critical to the adoption of new genomic technologies. We will discuss new findings from a unique Payer Coverage Policy Registry that examines what multigene tests are covered and the evidence used in coverage decisions. We will report lessons learned from case studies of tests covered or not covered.